Who we are
BMG Pharma is involved in the development of new healthcare products in the areas of oral care, dermatology including aesthetics, anaemia, osteoarthritis & cancer supportive care.
The company has created a strong portfolio of intellectual property which it has developed into a number of products that have been partnered with companies around the world.
The company recently merged with Sigea,an Italian company with expertise in targeted functional ingredients development currently focused on modified sodium hyaluronate for application in a number of therapeutic areas including dermatology and oral care. This merger will allow BMG to accelerate the development of a number of new products to complement its portfolio.